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ORIGINAL ARTICLE
Socioeconomic deprivation and the outcome of
pulmonary rehabilitation in England and Wales
Michael C Steiner,1 Derek Lowe,2 Katy Beckford,3 John Blakey,4 Charlotte E Bolton,5
Sarah Elkin,6 William D -C Man,7,8 C Michael Roberts,9 Louise Sewell,10
Paul Walker,11 Sally J Singh1
ABSTRACT
Background Pulmonary rehabilitation (PR) improves
exercise capacity and health status in patients with
COPD, but many patients assessed for PR do not
complete therapy. It is unknown whether socioeconomic
deprivation associates with rates of completion of PR or
the magnitude of clinical beneﬁts bequeathed by PR.
Methods PR services across England and Wales
enrolled patients to the National PR audit in 2015.
Deprivation was assessed using Index of Multiple
Deprivation (IMD) derived from postcodes. Study
outcomes were completion of therapy and change in
measures of exercise performance and health status.
Univariate and multivariate analyses investigated
associations between IMD and these outcomes.
Results 210 PR programmes enrolled 7413 patients.
Compared with the general population, the PR sample
lived in relatively deprived neighbourhoods. There was a
statistically signiﬁcant association between rates of
completion of PR and quintile of deprivation (70% in
the least and 50% in the most deprived quintiles). After
baseline adjustments, the risk ratio (95% CI) for patients
in the most deprived relative to the least deprived
quintile was 0.79 (0.73 to 0.85), p<0.001. After
baseline adjustments, IMD was not signiﬁcantly
associated with improvements in exercise performance
and health status.
Conclusions In a large national dataset, we have
shown that patients living in more deprived areas are
less likely to complete PR. However, deprivation was not
associated with clinical outcomes in patients who
complete therapy. Interventions targeted at enhancing
referral, uptake and completion of PR among patients
living in deprived areas could reduce morbidity and
healthcare costs in such hard-to-reach populations.
INTRODUCTION
COPD is an important and prevalent non-
communicable long-term condition that imposes a
signiﬁcant burden of mortality and morbidity
worldwide.1 The prevalence and impact (eg, the
risk of hospitalisation) of COPD has been shown to
be associated with poor socioeconomic status in
many countries including the UK.2 3 National clin-
ical audits of hospital care (2014) in England and
Wales (E&W) have similarly demonstrated a gradi-
ent of prevalence across socioeconomic strata.4
Clinical trials of pulmonary rehabilitation (PR)
have demonstrated unequivocal and substantial
improvements in breathlessness, exercise limitation
and health status in people with COPD.5 The 2015
E&W national audit of PR comprehensively
appraised services and patient outcomes in a cohort
of over 7000 patients attending an assessment for
PR, providing for the ﬁrst time a detailed assessment
of the effectiveness of PR ‘in the ﬁeld’.6 The audit
has conﬁrmed that the beneﬁts of PR observed in
clinical trials are delivered at a comparable magni-
tude in real-life clinical practice in patients who
attend and complete therapy. However, the audit
also conﬁrms that many patients do not enrol or
complete their course of PR and as expected there is
heterogeneity in the response to therapy. Previous
studies conducted in single centres or regions have
investigated factors predicting PR adherence, com-
pletion and clinical response but due to limitations
of sample size and geographical scope have not
identiﬁed clear-cut patient level indicators predict-
ing these outcomes.7–12 In particular, it is unknown
whether social deprivation (across the breadth of
national socioeconomic strata) is a predictor of these
Key messages
What is the key question?
▸ Are clinical outcomes (improvement in exercise
performance and health status) and completion
of pulmonary rehabilitation (PR) associated
with socioeconomic deprivation in patients
with COPD?
What is the bottom line?
▸ Using data from the national audit of PR
clinical outcomes in England and Wales, we
demonstrate that patients living in more
socially deprived areas are less likely to
complete a programme of PR, but clinical
outcomes in those who do ﬁnish treatment are
similar to those referred from less deprived
areas.
Why read on?
▸ Targeted interventions aimed at enhancing
referral, uptake and completion of PR among
patients with COPD living in deprived areas
have the potential to improve health outcomes
in this population.
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outcomes of therapy. This is an important question because PR is
one of the few interventions in COPD that has been shown to
reduce subsequent healthcare resource utilisation (and costs)
including days spent in hospital.13 14 Given that the risk of hospi-
talisation is also greater in populations with low socioeconomic
status,15 16 an understanding of the relationship between social
disadvantage and other disease or demographic factors and the
prediction of successful attendance and completion of PR might
allow targeted interventions/resource aimed at enhancing both
the uptake and completion of PR as well as clinical outcomes in
particular groups of patients. This could in turn reduce morbidity
and healthcare costs in hard-to-reach populations such as those at
social disadvantage.
In the E&W national PR audit, individual patient postcodes
were used to obtain a set of deprivation indices (Index of
Multiple Deprivation (IMD)) pertaining to the area in which
the patient lived at the time of their assessment for treatment. In
this study, we determined whether completion of treatment and
clinical outcomes recorded during the audit were associated
with IMD and whether any such associations held true when
adjusted for other disease and demographic variables recorded
at baseline assessment for PR.
METHODS
Audit methodology
The National COPD Audit Programme, commissioned by the
Healthcare Quality Improvement Partnership (HQIP) as part of
the National Clinical Audit Programme (NCA), delivers a pro-
gramme of work that aims to drive improvements in the quality
of care and services provided for patients with COPD in E&W.
The programme is led by the Royal College of Physicians,
working in partnership with the British Thoracic Society, the
British Lung Foundation, the Primary Care Respiratory Society
UK, the Royal College of General Practitioners and the Health
and Social Care Information Centre.
The ﬁrst national audit of clinical outcomes of PR in E&W
reported clinical outcomes in 2016.6 A detailed account of the
audit methodology is provided in the online supplementary
material and reports are also publicly accessible at http://www.
rcplondon.ac.uk/projects/national-copd-audit-programme-
pulmonary-rehabilitation-workstream.
Prior to undertaking the audit, PR services across E&W were
comprehensively surveyed and mapped (see online supplementary
material for details) with 230 programmes invited to enrol
patients. Programmes were requested to audit all patients with a
primary respiratory diagnosis of COPD who attended an initial
assessment for PR between 12 January 2015 and 10 April 2015,
with a further 3-month period (to 10 July 2015) to allow the
patients who had been recruited and consented to complete their
PR and for data to be entered onto the online data collection tool.
The clinical audit dataset was developed by the PR workstream
group, in consultation with COPD experts across E&W. The
dataset is provided in the online supplementary material and is
also available to download via the weblink above. Section 251
approval was obtained via the National Conﬁdentiality Advisory
Group for the collection of patient identiﬁable data. Caldicott
Guardian approval was obtained from each participating unit
before access to the online audit web tool was granted and patients
enrolled to the audit provided individual written consent before
their data were uploaded.
Index of multiple deprivation
Deﬁnitions and assessment of deprivation and socioeconomic
position are complex.17 Social deprivation arises from the
inequity of an individual’s socioeconomic position comparative
to others, formed from the hierarchical distribution of wealth,
welfare and opportunity within society.18 Deprivation covers a
broad range of issues and refers to unmet needs caused by a lack
of resources of all kinds, not just ﬁnancial.
E&W produce their own separate indices of multiple depriv-
ation (http://www.neighbourhood.statistics.gov.uk/dissemination/
MetadataDownloadPDF;
http://www.gov.uk/government/uploads/system/uploads/
attachment_data/ﬁle/6222/1871538.pdf ), with scores that are
not directly comparable. For this audit, patient postcodes were
used to obtain a set of deprivation indices data pertaining to the
area in which the patient lived at the time of their enrolment to
PR; these data being publicly available.
Clinical outcomes
Three outcomes were chosen to reﬂect success or otherwise in
various aspects of a PR programme. First, patients were consid-
ered to have completed PR if they attended a discharge assess-
ment (irrespective of attendance rates during the programme),
where other outcomes were recorded. The other two outcomes
relate to improvements in health status and in exercise perform-
ance, and applied to those with relevant baseline and discharge
values. The Incremental Shuttle Walk test (ISWT) and the 6 min
walk test (6MWT) were amalgamated by taking the percentage
change from initial to discharge assessment. Health status mea-
sures comprised the St George’s Respiratory Questionnaire
(SGRQ), the Chronic Respiratory Questionnaire (CRQ) and the
COPD Assessment Test (CAT). Since these ordinal scales were
unsuitable for computing percentage change, a combined health
status outcome was obtained by amalgamating minimum clinic-
ally important differences (MCID). The MCID for the SGRQ
was a reduction of 4 points in the total score, for the CRQ an
increase of 0.5 points in the average of the four domain scores
and for the CAT a reduction of 2 points.19–21 The combined
health status outcome measure was then the achievement of any
of these MCID. Baseline scores for exercise and health status
were categorised into quartiles—best quartile through to worst
quartile of scores. Patients having more than one type of assess-
ment (eg, ISWT and 6MW for exercise, or SGRQ and CAT for
health status) were placed according to the assessment quartile
they performed best on. These and all other baseline patient/
clinical characteristics used in the analysis were as categorised in
table 2.
Statistical analysis
The χ2 test was used to test for association between deprivation
quintiles and other baseline characteristics, for association
between baseline characteristics and whether or not patients
attended a discharge assessment and (for those with relevant
data) whether an MCID was achieved in regard to health status.
The Mann-Whitney U test (2 groups) or Kruskal-Wallis test (>2
groups) was used to test for association in the percentage
change in exercise distance, the distribution of which was
notably skewed. Preliminary visual graphical inspection of out-
comes by IMD within each stratum of factors in table 1 and
baseline assessment quartiles was undertaken to inspect for evi-
dence of interaction. No such evidence was found. Binary
regression (STATA binreg procedure, rr link option) was used to
assess the association of deprivation quintile with whether or
not patients attended a discharge assessment, and with whether
or not an MCID in health status was achieved. Median regres-
sion (STATA qreg/qreg2 procedures) was used to assess the asso-
ciation of deprivation quintile with percentage change in
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exercise scores; the object being to estimate the median of the
dependent outcome variable, conditional on the values of the
independent variables. Risk ratios (binary regression) or coefﬁ-
cients (median regression) were estimated, with adjustments
made for possible confounder variables as independent predic-
tors (those described in table 1, together with baseline quartiles
for health status and exercise). p Values and CIs were also esti-
mated and adjusted for programme clustering effects; SEs that
are robust to intracluster correlation were obtained for both
types of regression by using the option ‘cluster’. Unknown data
were coded to preserve the full sample size in the regression,
notably affecting Medical Research Council (MRC) grade and
body mass index. Due to the number of tests performed, statis-
tical signiﬁcance was regarded as p<0.001. Also, the large
sample sizes sometimes resulted in small, clinically non-relevant
differences being statistically signiﬁcant and this is reﬂected in
the overall interpretation.
Additional analyses were performed to consider the potential
impact that categorising IMD may have had, particularly in
regard to discharge assessment. These were done for England
alone (96% of all cases) since the numerical scale for Wales was
different. Random effects logistic regression was also used as an
alternative to binary regression. Additional results are provided
in online supplementary material.
Role of the funding source
The National COPD Audit Programme is commissioned by the
HQIP (http://www.HQIP.org.uk) as part of the NCA. The NCA
is funded by NHS England, the Welsh Government and, with
some individual audits, also funded by the Health Department
of the Scottish Government, Department of Health, Social
Services and Public Safety (DHSSPS) Northern Ireland and the
Channel Islands. The authors are independent from HQIP and
the audit funders who had no inﬂuence over the writing of the
manuscript.
RESULTS
Two hundred and ten programmes (195 in England and 15 in
Wales) enrolled 7413 patients to the audit. Based on individual
programme activity data provided as part of the audit of the
organisation and resources of PR22 for the same case acquisition
time period as the clinical audit (12 January to 15 April 2015),
the response rate was estimated as 73% of eligible patients. The
reason for non-enrolment was because either the patient was
Table 1 Prevalence of sample characteristics at baseline across IMD deprivation quintiles results where the association was statistically
significant at the 5% level
IMD
Q1 most deprived Q2 Q3 Q4 Q5 least deprived Total p Value*
All patients 26% 1915 22% 1570 20% 1476 17% 1256 14% 1046 7263 <0.001†
Gender
Male 25% 959 21% 825 20% 785 18% 709 15% 592 3870 0.001
Female 28% 956 22% 745 20% 691 16% 547 13% 454 3393
Age
<60 43% 495 23% 266 18% 207 11% 121 5% 61 1150 <0.001
60–64 32% 322 23% 229 20% 198 15% 150 10% 95 994
65–69 25% 392 21% 337 21% 327 18% 290 14% 225 1571
70–74 22% 322 21% 310 20% 303 17% 257 20% 290 1482
75–79 19% 223 21% 246 20% 234 23% 260 16% 184 1147
≥80 18% 161 20% 182 23% 207 19% 178 21% 191 919
Smoking status
Current 38% 600 23% 357 18% 291 13% 206 8% 120 1574 <0.001
<0.001Ex 23% 1179 22% 1111 21% 1056 18% 923 16% 812 5081
Never 17% 77 18% 78 22% 97 23% 104 20% 88 444
Not known 36% 59 15% 24 20% 32 14% 23 16% 26 164
Mental health disorder comorbidity
No 26% 1725 22% 1456 21% 1382 17% 1176 15% 991 6730 <0.001
Yes 36% 190 21% 114 18% 94 15% 80 10% 55 533
Patient’s living arrangements
House/flat with other 24% 1076 21% 961 21% 930 18% 827 16% 702 4496 <0.001
<0.001House/flat alone 32% 651 22% 460 19% 399 15% 311 11% 235 2056
Other 33% 52 25% 40 20% 32 15% 23 6% 10 157
Not known 25% 136 20% 109 21% 115 17% 95 18% 99 554
Patient-reported MRC dyspnoea score at assessment
Grades 1/2 22% 254 19% 221 22% 262 18% 206 20% 230 1173 <0.001
<0.001Grade 3 25% 655 21% 556 21% 539 19% 481 14% 359 2590
Grade 4 28% 644 24% 552 19% 438 16% 366 13% 288 2288
Grade 5 29% 185 22% 140 20% 123 16% 98 13% 84 630
Not known 30% 177 17% 101 20% 114 18% 105 15% 85 582
Note: Percentages for the reported variables total 100% horizontally across the IMD quintiles.
*χ2 test: first p values exclude not known, second p value includes not known.
†Goodness-of-fit test: null hypothesis—all five quintile categories have equal frequencies.
IMD, Index of Multiple Deprivation; MRC, Medical Research Council.
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Table 2 Univariate associations for the three study outcomes by each of the study baseline variables
% of those assessed
attending a discharge assessment p Value*
% achieving
MCID in health status† p Value*
% change in ISWT/6MWT
exercise test distance
Median (IQR), N p Value‡
All patients 59% (4353/7413) 61% (2240/3664) 25 (8–54), n=3901
(W)IMD
Q1 most deprived 50% (951/1915) <0.001
<0.001
60% (458/760) 0.20
0.30
27 (9, 63), n=843 <0.001
<0.001Q2 55% (860/1570) 64% (473/736) 29 (11, 59), n=782
Q3 62% (919/1476) 62% (489/786) 23 (7, 50), n=823
Q4 63% (801/1256) 59% (401/685) 23 (7, 49), n=719
Q5 least deprived 70% (736/1046) 60% (373/623) 22 (6, 47), n=658
Not known 57% (86/150) 62% (46/74) 22 (7, 46), n=76
Gender
Male 60% (2353/3948) 0.10 62% (1224/1976) 0.28 23 (7, 50), n=2136 <0.001
Female 58% (2000/3465) 60% (1016/1688) 27 (10, 58), n=1765
Age
<60 45% (525/1180) <0.001 64% (281/439) 0.15 33 (15,70), n=459 <0.001
60–64 56% (570/1020) 60% (294/491) 23 (7, 54), n=531
65–69 61% (985/1604) 60% (500/839) 24 (9, 50), n=889
70–74 63% (945/1505) 63% (504/802) 22 (7, 50), n=860
75–79 63% (739/1167) 63% (389/616) 23 (7, 50), n=651
≥80 63% (589/937) 57% (272/477) 26 (6, 64), n=511
Ethnicity
White: British/Irish/other 59% (4006/6772) 0.13
0.05
61% (2062/3368) 0.17
0.12
25 (8, 54), n=3582 0.23
0.30Other 54% (108/201) 68% (65/95) 31 (9, 63), n=100
Not known 54% (239/440) 56% (113/201) 23 (8, 46), n=219
Previous PR completion
Yes 62% (734/1175) 0.006
0.01
59% (361/611) 0.24
0.50
22 (7, 47), n=648 0.03
0.08No 58% (3286/5650) 62% (1700/2758) 25 (8, 54), n=2952
Not known 57% (333/588) 61% (179/295) 27 (8, 62), n=301
Smoking status
Current 47% (753/1614) <0.001
<0.001
58% (359/619) 0.15
0.27
25 (8, 55), n=662 0.44
0.22Ex 62% (3214/5179) 62% (1676/2725) 24 (8, 53), n=2904
Never 66% (296/449) 64% (160/249) 27 (11, 52), n=258
Not known 53% (90/171) 63% (45/71) 33 (8, 91), n=77
No. of comorbidities (0–23)
0 61% (1074/1771) 0.001 62% (559/902) 0.16 22 (8, 50), n=958 <0.001
1 60% (1446/2397) 59% (714/1210) 24 (7, 50), n=1305
2 59% (978/1662) 61% (517/850) 27 (8, 52), n=891
3 54% (501/931) 66% (276/419) 26 (9, 57), n=443
≥4 54% (354/652) 61% (174/283) 35 (13, 68), n=304
Cardiovascular comorbidity§
No 58% (2259/3880) 0.36 60% (1156/1915) 0.32 24 (8, 53), n=2029 0.34
Yes 59% (2094/3533) 62% (1084/1749) 26 (8, 54), n=1872
Diabetes comorbidity
No 59% (3794/6426) 0.15 61% (1942/3184) 0.65 24 (8, 53), n=3397 0.07
Yes 57% (559/987) 62% (298/480) 27 (10, 60), n=504
Locomotor problems comorbidity
No 60% (3912/6557) <0.001 61% (2022/3297) 0.47 25 (8, 53), n=3528 0.20
Yes 52% (441/856) 59% (218/367) 30 (7, 61), n=373
Mental health disorder comorbidity
No 60% (4090/6871) <0.001 61% (2101/3441) 0.71 24 (8, 53), n=3659 <0.001
Yes 49% (263/542) 62% (139/223) 32 (14, 72), n=242
No. of times patient hospitalised for a COPD exacerbation in the past 12 months
0 61% (2692/4382) <0.001
<0.001
60% (1372/2269) 0.53
0.62
24 (8, 50), n=2441 0.001
0.0031 59% (789/1330) 61% (397/648) 26 (8, 57), n=693
≥2 47% (286/608) 64% (154/240) 36 (12, 72), n=244
Not known 54% (586/1093) 63% (317/507) 24 (8, 54), n=523
Oxygen therapy at home at the time of assessment
Yes 54% (318/590) 0.008
<0.001
58% (153/265) 0.24
0.48
26 (0, 60), n=263 0.72
0.84No 59% (3971/6674) 61% (2056/3347) 25 (8, 53), n=3583
Continued
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not approached or declined to provide consent for their data to
be used. (W)IMD deprivation data was available for 7263
patients, but unknown for 150 (2%) (across 75 programmes). If
the COPD PR audit sample living in E&W was comparable to
E&W as a whole, then 20% of the sample would live within
each national quintile of postcode areas. This was not so
(goodness-of-ﬁt test, p<0.001, table 1). The sample was rela-
tively deprived with 48% living in the two most deprived quin-
tiles and only 31% in the two ‘least deprived’ quintiles. Table 1
shows statistically signiﬁcant associations between deprivation
quintile and other baseline variables. Analysis of associations
between undertaking of baseline exercise and health status
assessments and IMD quintiles is provided in the online
supplementary material. Of the initial sample, 6772 (91%) were
‘white British or Irish or from any other white background’,
201 (3%) were ‘other ethnic groups’ and 440 (6%) were ‘not
stated’. The number of cases from other ethnicities was too
small to allow a meaningful analysis of PR completion or
outcome by ethnic group.
Baseline characteristics of the sample and the univariate asso-
ciation with the three audit outcomes are shown in table 2.
Many baseline factors were associated with attendance at a dis-
charge assessment, which was achieved for 4456 (59%) overall.
Of these, data for health status and exercise measures was avail-
able for 3664 and 3901, respectively. There was a gradient in
attendance at a discharge assessment by IMD quintile, with
Table 2 Continued
% of those assessed
attending a discharge assessment p Value*
% achieving
MCID in health status† p Value*
% change in ISWT/6MWT
exercise test distance
Median (IQR), N p Value‡
Not known 43% (64/149) 60% (31/52) 27 (8, 58), n=55
Patient’s living arrangements
House/flat with other 60% (2752/4593) 0.003
0.001
62% (1450/2340) 0.001
0.001
25 (8, 54), n=2470 0.94
0.97House/flat alone 58% (1220/2100) 59% (594/1013) 25 (8, 53), n=1089
Other 47% (75/159) 83% (48/58) 23 (0, 63), n=62
Not known 55% (306/561) 58% (148/253) 24 (7, 50), n=280
FEV1
≤0.92 59% (662/1128) 0.04
<0.001
59% (340/579) 0.13
0.19
25 (7, 54), n=586 0.25
0.400.93–1.27 64% (716/1115) 60% (363/608) 25 (8, 50), n=628
1.28–1.71 62% (690/1108) 64% (375/588) 23 (7, 50), n=636
1.72+ 60% (653/1089) 64% (363/566) 25 (9, 56), n=590
Not known 55% (1632/2973) 60% (799/1323) 25 (8, 56), n=1461
Body mass index
<21 55% (376/688) <0.001
<0.001
53% (161/304) 0.01
0.02
25 (7, 62), n=334 0.008
0.0121–24 62% (712/1140) 62% (373/601) 22 (8, 48), n=638
25–29 63% (979/1544) 63% (520/828) 25 (10, 51), n=877
30–34 62% (540/865) 65% (304/466) 25 (8, 54), n=487
35 or above 58% (381/661) 61% (201/332) 32 (12, 73), n=340
Not known 54% (1365/2515) 60% (681/1133) 25 (7, 50), n=1225
Patient-reported MRC dyspnoea score at assessment
Grades 1/2 64% (760/1195) <0.001
<0.001
55% (360/650) 0.003
0.006
18 (6, 35), n=708 <0.001
<0.001Grade 3 63% (1669/2656) 62% (893/1435) 23 (8, 48), n=1531
Grade 4 56% (1302/2328) 62% (690/1107) 33 (10, 71), n=1139
Grade 5 49% (312/643) 67% (147/218) 46 (15, 100), n=238
Not known 52% (310/591) 59% (150/254) 25 (10, 53), n=285
ISWT/6MWT distance quartiles at initial assessment
1. Worst quartile 54% (898/1676) <0.001
<0.001
62% (465/746) 0.11
0.03
78 (33, 150), n=824
2 61% (1087/1785) 59% (551/931) 33 (13, 59), n=1005
3 68% (1040/1538) 64% (579/900) 20 (5, 36), n=983 <0.001
4. Best quartile 69% (1137/1640) 60% (595/988) 14 (3, 25), n=1089
No ISWT/6MWT 25% (191/774) 51% (50/99) –
SGRQ total/CRQ average/CAT score quartiles at initial assessment
1. Worst quartile 51% (634/1247) <0.001
<0.001
76% (466/617) 40 (15, 86), n=571 <0.001
<0.0012 62% (978/1584) 70% (665/952) 30 (11, 65), n=892
3 68% (950/1399) 64% (586/920) <0.001 22 (7, 46), n=864
4. Best quartile 72% (1210/1690) 45% (523/1175) 19 (5, 38), n=1113
No SGRQ/CRQ/CAT 39% (581/1493) – 25 (7, 66), n=461
*χ2 test: first p values exclude not known, 2nd p value includes not known.
†Combined outcome with a MCID achieved in any of the following: for the SGRQ the MCID was a reduction of 4 points in the total score, for the CRQ the MCID was an increase of 0.5
points in the average of the four domain scores and for the CAT the MCID was a reduction of 2 points.
‡Mann-Whitney U test (2 groups) or Kruskal-Wallis test (>2 groups): first p values exclude not known, second p value includes not known.
§Any of atrial fibrillation, hypertension, heart failure, ischaemic heart disease, stroke, other cardiovascular.
6MWT, 6 min walk test; CAT, COPD Assessment Test; CRQ, Chronic Respiratory Questionnaire; IMD, Index of Multiple Deprivation; ISWT, Incremental Shuttle Walk test; MCID, minimum
clinically important differences; MRC, Medical Research Council; PR, pulmonary rehabilitation; SGRQ, St George’s Respiratory Questionnaire.
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discharge assessment achieved by 70% in the least deprived
quintile and by 50% in the most deprived quintile. A number of
baseline sample characteristics were associated with rate of
attendance at a discharge assessment and changes in walking
performance and health status recorded at the assessment (see
table 2 and more detailed description in the online
supplementary material).
Regression analyses to assess the association of IMD depriv-
ation quintile with each outcome both before and after adjusting
for other baseline variables that were associated with both IMD
and outcome are presented in tables 3–5. Adjustments were made
for the variables from table 1, together with baseline exercise and
health status as appropriate, and for PR programme clustering
effects (for more detail see online supplementary material). In
respect of patients having a discharge assessment, adjustments in
the binary regression did diminish the IMD quintile gradient
(table 3), but a statistically signiﬁcant association remained; the
risk ratio (95% CI) for patients in the most deprived quintile rela-
tive to patients in the least deprived quintile was 0.79 (0.73 to
0.85), that is a 21% (15%–27%) less chance of having a dis-
charge assessment. Furthermore, an IMD gradient was observed
at each categorisation level of all others variables listed in table 2
(results not shown). In regard to achieving MCIDs for health
status, the binary regression adjustment for all table 1 variables
was not achieved because of model convergence issues. However,
adjustment was possible for the two most predictive variables,
namely baseline score quartile and MRC dyspnoea score. After
adjustment no statistically signiﬁcant (p<0.001) risk ratios were
seen (table 4). Regarding percentage change in ISWT/6MWT
exercise test distance, the better results for patients living in more
deprived areas suggested by unadjusted univariate analyses were
largely extinguished after adjustment for baseline exercise score
quartile and other variables (table 5).
DISCUSSION
Using data from the ﬁrst national audit of PR clinical outcomes in
E&W, we have demonstrated for the ﬁrst time at a national level
that patients living in more socially deprived areas are less likely
to complete therapy. Patients from more deprived IMD quintiles
who completed PR were less likely to achieve a gain in health
status above accepted thresholds for clinically important change
but this association disappeared after adjustment for other base-
line variables apart from those from the lowest IMD quintile.
After adjustment for baseline variables, IMD was not associated
with gains in exercise performance in those completing PR.
The E&W national audit of PR has provided the largest audit
dataset (>7000 patients) of PR outcomes in COPD to date
worldwide and has offered an opportunity to investigate, in a
large nationwide sample, clinical and sociodemographic associa-
tions with rates of PR completion and gains in health status and
exercise performance. In addition to IMD quintile, we identiﬁed
a number of other variables recorded at baseline assessment for
PR (presented in table 2) that were associated with PR comple-
tion. These included factors that in themselves were associated
with IMD and may therefore have confounded the relationship
between IMD and completion such as smoking status and living
circumstances (shown in table 1). However, in the multivariate
regression analysis, the gradient of completion rates across IMD
quintiles remained signiﬁcant after adjusting for these variables.
The relationship between IMD quintile and the clinical outcome
of treatment (assessed using health status instruments and ﬁeld
walking tests) was less clear cut. This analysis may have also
been inﬂuenced by differences at baseline in health status and
exercise measures across IMD quintiles (although adjustment for
baseline values was included in the multivariate analysis) and
also by methods used to assess improvement across these
groups. For health status, improvement above accepted MCIDs
Table 3 Binary regression risk ratio (with 95% CI and p value) of reaching a discharge assessment for IMD deprivation quintile relative to the
reference group of least deprived IMD quintile, for 7413 patients
IMD quintile Unadjusted risk ratio (95% CI)
After adjusting for table 1 variables*
and programme clustering effects
Q1 most deprived 0.71 (0.66 to 0.75), p<0.001 0.79 (0.73 to 0.85), p<0.001
Q2 0.78 (0.73 to 0.83), p<0.001 0.84 (0.77 to 0.90), p<0.001
Q3 0.88 (0.84 to 0.94), p<0.001 0.92 (0.86 to 0.98), p=0.02
Q4 0.91 (0.86 to 0.96), p=0.001 0.94 (0.88 to 1.00), p=0.05
Q5 least deprived Reference risk ratio=1.00 Reference risk ratio=1.00
Not known 0.81 (0.71 to 0.94), p=0.005 0.88 (0.75 to 1.04), p=0.14
*Gender, age group, smoking status, mental health disorder comorbidity, patients living arrangements and patient-reported MRC dyspnoea score at initial assessment.
IMD, Index of Multiple Deprivation; MRC, Medical Research Council.
Table 4 Binary regression risk ratio (with 95% CI and p value) of achieving a minimum clinically important improvement in health status for
IMD deprivation quintile relative to the reference group of least deprived IMD quintile for 3664 patients
IMD quintile Unadjusted risk ratio (95% CI)
After adjusting for baseline health status
score quartile and PR programme clustering effects
After adjusting for baseline health
status score quartile, patient-reported
MRC dyspnoea score at initial
assessment and PR programme clustering effects
Q1 most deprived 1.01 (0.92 to 1.10), p=0.88 0.91 (0.84 to 0.99), p=0.03 0.91 (0.84 to 0.99), p=0.03
Q2 1.07 (0.99 to 1.17), p=0.10 0.99 (0.93 to 1.06), p=0.83 0.99 (0.92 to 1.06), p=0.79
Q3 1.04 (0.96 to 1.13), p=0.37 0.98 (0.91 to 1.06), p=0.58 0.98 (0.91 to 1.05), p=0.56
Q4 0.98 (0.89 to 1.07), p=0.62 0.93 (0.86 to 1.01), p=0.08 0.93 (0.87 to 1.01), p=0.08
Q5 least deprived Reference risk ratio=1.00 Reference risk ratio=1.00 Reference risk ratio=1.00
Not known 1.04 (0.86 to 1.25), p=0.70 0.98 (0.81 to 1.19), p=0.84 0.97 (0.80 to 1.18), p=0.75
IMD, Indices of Multiple Deprivation; MRC, Medical Research Council; PR, Pulmonary Rehabilitation.
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for the three instruments recorded in the audit (the SGRQ,
CRQ and CAT) was calculated because the ordinal nature of
health status data precludes meaningful calculation of propor-
tionate change. For exercise measures (ISWTand 6MWD), com-
posite proportionate improvements were calculated partly to
maximise the information provided from a continuous variable
and also because the most recently cited MCIDs for these tests
are markedly different (27 m for the 6MWD and 48 m for the
ISWT).23 This proportionate change may have been affected by
the absolute baseline value which was different across IMD
quintiles, potentially explaining why unadjusted gains in exercise
performance were greater in more deprived IMD quintiles.
However, overall when adjusted for these differences, IMD did
not predict change in exercise performance resulting from PR.
Taken together, the results suggest that socioeconomic depriv-
ation is a key factor determining the likelihood of completion of
PR but for those that do complete treatment, other factors are
more important in determining treatment response.
Our ﬁnding of a greater prevalence of patients referred to PR
in lower IMD quintiles is in keeping with previous reports
linking socioeconomic deprivation to COPD prevalence, out-
comes and health resource utilisation.2 3 16 24 Similarly, using an
identical methodology to assess deprivation, the national clinical
audit of acute hospital care in COPD conducted in 2014
observed a signiﬁcant gradient of prevalence across IMD quin-
tiles.4 Indeed, the disparity of prevalence across these quintiles
was greater in the national hospital audit than seen in the PR
audit. We speculate that this is due to differences in rates of the
offer and uptake of PR referral in more deprived populations.
Although the PR audit did not assess referral practice, it may be
therefore that patients from more deprived areas are less likely
to complete treatment and are less likely to be referred to PR in
the ﬁrst place.
Previous reports have attempted to identify factors that predict
the successful outcome of PR in COPD.9 Some have identiﬁed
baseline variables such as current smoking, presence of comorbid-
ities, psychological morbidity and access to transport that predict
PR completion and outcome.25 26 However, most reports are
restricted to studies in single centres or discrete geographical areas
with comparatively small sample sizes and variance in outcome
explained by these indices was insufﬁcient to allow discrimination
in referral criteria for PR.8 10 It is also recognised that the beneﬁt
of PR extends beyond measurable outcome variables such as
health status and exercise performance. This was highlighted by
a recent large-scale single-centre study in the Netherlands where
differential responses to PR were characterised using
multidimensional modelling of a number of outcomes that
included ‘activity of daily living’ scales, depression and anxiety.27
However, this focused on clinical and physiological variables
recorded at baseline PR assessment and did not include social or
deprivation indices. Factors such as lack of access to transport to
PR services or active smoking may be markers of social depriv-
ation, but to our knowledge, none has reported the association of
indices of social deprivation with PR outcome at a national scale.
We recognise limitations to the interpretation of our data.
IMD quintiles are derived from individual postcodes and there-
fore provide a relative measure of deprivation at small area
level. As such, IMD relates to areas and not individuals—within
each area there will be both individuals who are deprived and
individuals who are not. As with any regression analysis, the
variance in the independent variable that is explained depends
on the breadth and character of the dependent variables
recorded. In this case, this was determined by the audit dataset
which was in turn governed by the quality standards against
which the outcome of the audit was assessed and the need to
assess casemix as a means to interpret these outcomes. The
assessment of the outcome of treatment was restricted to those
completing a discharge assessment and was measured variably
among programmes (ISWT or 6MWT for exercise performance
and CRQ, SGRQ or CAT for health status). We recognise that
combining these outcomes in our analysis may fail to distinguish
subtle differences in how these instruments perform in the ﬁeld
and risk artefact due to differences relative responsiveness and
thresholds for change between them. However, we believe the
beneﬁt of providing a uniﬁed analysis at a national level that can
be generalised to programmes across E&W outweighs these
caveats. Finally, while we believe this to be a comprehensive
picture of services in E&W, we cannot rule out the possibility
that PR services exist that were not identiﬁed and contacted,
and therefore did not participate in the audit.
Our ﬁndings have implications for the planning and provision
of PR services. The PR audit has highlighted the clinical value of
exercise therapies for people with COPD but also suggests that too
few patients are being referred for PR, take up the offer of referral
or complete therapy.6 Given that the available evidence suggests
that completion of PR reduces subsequent health resource utilisa-
tion (such as days spent in hospital),13 14 increasing patient referral
and service provision of PR is a key health policy objective. Given
the greater risk of hospital admission and poor health outcomes in
patients living in deprived areas, enhancing access to PR among
people living in such areas should be a priority. This may require a
number of measures some of which may be straightforward such
Table 5 Median regression coefficients (with 95% CI and p value) for IMD quintile relative to the reference group of least deprived quintile, in
the percentage change of ISWT/6MWT exercise test distances for 3901 patients
IMD quintile
Unadjusted coefficient
(95% CI)
After adjusting for baseline ISWT/6MWT
exercise score quartile and PR programme
clustering effects
After adjusting for table 1 variables*, baseline
ISWT/6MWT exercise score quartile
and PR programme clustering effects
Q1 most deprived 5.43 (1.56 to 9.30), p=0.006 2.17 (−1.48 to 5.83), p=0.24 −0.03 (−4.10 to 4.04), p=0.99
Q2 6.70 (2.76 to 10.6), p=0.001 4.55 (1.03 to 8.07), p=0.01 3.43 (−0.71 to 7.58), p=0.10
Q3 1.20 (-2.69 to 5.09), p=0.55 0.07 (−3.72 to 3.86), p=0.97 −1.00 (−5.31 to 3.32), p=0.65
Q4 1.20 (-2.81 to 5.21), p=0.56 0.07 (−3.70 to 3.83), p=0.97 −0.26 (−4.20 to 3.67), p=0.90
Q5 least deprived Reference coefficient=0.00 Reference coefficient=0.00 Reference coefficient=0.00
Not known 0.35 (−8.66 to 9.36), p=0.94 2.17 (−3.54 to 7.88), p=0.46 2.62 (−3.89 to 9.13), p=0.43
Note about coefficients: these estimate the difference in the median (percentage change) in the regression equation with respect to IMD quintile. In the last two columns this is after
other variables have been fixed (adjusted for) in the regression equation.
*Gender, age group, smoking status, mental health disorder comorbidity, patients living arrangements and patient-reported MRC dyspnoea score at initial assessment.
6MWT, 6 min walk test; IMD, Index of Multiple Deprivation; IPR, pulmonary rehabilitation; MRC, Medical Research Council; SWT, Incremental Shuttle Walk test.
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as making transport to PR services available and some more difﬁ-
cult such as raising awareness of the beneﬁts of PR to patients
from deprived areas and changing referral practice among health-
care workers who provide care in these areas.
In summary, using data from the national audit of PR in COPD
across E&W, we have shown that rates of successful completion of
therapy are lower in patients frommore socioeconomically deprived
areas, but that in those that complete therapy patients from all strata
of deprivation gain similar beneﬁt from PR. Given that PR is the
most effective therapy available for people with COPD, targeted
interventions aimed at enhancing referral, uptake and completion
of PR among patients living in deprived areas could reduce morbid-
ity and healthcare costs in such hard-to-reach populations.
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